References

1. Cottin V, Archer F, Khouatra C, Lazor R, Cordier JF. Lymphangioléimyomatose pulmonaire. Presse Med. 2010; 39(1): 116-125. PubMed | Google Scholar


2. Taveira-DaSilva AM, Pacheco-Rodriguez G, Moss J. The Natural History of Lymphangioleiomyomatosis: Markers of Severity, Rate of Progression and Prognosis. Lymphatic Research and Biology. 2010; 8 (1): 9-19. PubMed | Google Scholar


3. Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S et al. European Respiratory Society guidelines for the diagnosis and management of Lymphangioleiomyomatosis. Eur Respir J. 2010; 35(1): 14-26. PubMed | Google Scholar


4. Marie I1, Cailleux N, Henry J, Janvresse A, Muir JF, Lévesque H et al. Lymphangioleiomyomatose pulmonaire: une découverte souvent fortuite: à propos d?une observation. Rev Méd Interne. 1999; 20(9): 806-9. PubMed | Google Scholar


5. Kaufman J, Khatri BO, Riendl P. Are patients with multiple sclerosis protected from thrombophlebitis and pulmonary embolism? Chest. 1988 Nov; 94(5):998-1001. PubMed | Google Scholar


6. Wani NA, Kosar T, Gojwari T. Atypical presentation of lymphangioleiomyomatosis as jugular vein thrombosis. The British Journal of Radiology.2010; 83(988): e70-e73. PubMed | Google Scholar